[{"NetIncomeLoss_1_Q1_USD":-27723000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5672000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":51499831.0,"CommitmentsAndContingencies_0_Q1_USD":null,"PaidInKindInterest_1_Q1_USD":114000.0,"LiabilitiesNoncurrent_0_Q1_USD":26899000.0,"InterestPaidNet_1_Q1_USD":493000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":66728000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-29228000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":14000.0,"AssetsCurrent_0_Q1_USD":278947000.0,"DepositsAssetsCurrent_0_Q1_USD":4840000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":881000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":37500000.0,"CommonStockSharesIssued_0_Q1_shares":48248559.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":206949000.0,"Assets_0_Q1_USD":279672000.0,"ShareBasedCompensation_1_Q1_USD":2767000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":434000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q1_USD":9727000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":13000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":824542000.0,"LongTermLoansPayable_0_Q1_USD":15602000.0,"ShortTermInvestments_0_Q1_USD":206949000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":21870000.0,"LoansPayableCurrent_0_Q1_USD":4632000.0,"ProceedsFromStockPlans_1_Q1_USD":79000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-57000.0,"CommonStockValue_0_Q1_USD":5000.0,"Supplies_0_Q1_USD":58000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":960000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":162000.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":121000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":11414000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-27723000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-27710000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":3021000.0,"OtherAssetsNoncurrent_0_Q1_USD":115000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":64386000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":60000.0,"Liabilities_0_Q1_USD":51467000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"InterestReceivableCurrent_0_Q1_USD":279000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":660000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q1_USD":2285000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":23000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2767000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-22589000.0,"LoansPayable_0_Q1_USD":20234000.0,"LiabilitiesCurrent_0_Q1_USD":24568000.0,"AccountsPayableCurrent_0_Q1_USD":6529000.0,"NonoperatingIncomeExpense_1_Q1_USD":-560000.0,"InterestExpense_1_Q1_USD":623000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7612000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":881000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":197000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q1_USD":9000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":64501000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":100954.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q1_USD":7988000.0,"PrepaidInsurance_0_Q1_USD":2052000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":176000.0,"CommonStockSharesOutstanding_0_Q1_shares":48248559.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-50857000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-596351000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-113000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":379000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q1_USD":79000.0,"OperatingIncomeLoss_1_Q1_USD":-27163000.0,"InvestmentIncomeInterest_1_Q1_USD":120000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1517000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":279672000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1579000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-379000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":476000.0,"OperatingExpenses_1_Q1_USD":27542000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":41000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.54,"ProfitLoss_1_Q1_USD":-27723000.0,"StockholdersEquity_0_Q1_USD":228205000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":11237000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":20000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":206940000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2767000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":471000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210511"}]